Status:
RECRUITING
Diagnosis and Management of Intrauterine Growth Restriction and Congenital Anomalies
Lead Sponsor:
Guangzhou Women and Children's Medical Center
Conditions:
Intrauterine Growth Restriction
Fetal Anomaly
Eligibility:
All Genders
Up to 18 years
Brief Summary
The purpose of this prospective cohort study is to build a large platform that includes clinical information (prenatal diagnosis and postnatal follow-up data) and biological specimen banks of fetuses/...
Detailed Description
Intrauterine growth restriction (IUGR) and congenital anomalies are one of the important reasons for infant and childhood death, which carry a high burden to affected individuals and their families. T...
Eligibility Criteria
Inclusion
- All pregnant women who present to Guangzhou Women and Children's Medical Center meeting one of the following prenatal diagnoses and neonates/infants who are diagnosed as one of the following anomalies will be invited to participate:
- Intrauterine growth restriction (IUGR)
- Structural anomaly
- Chromosomal anomaly
Exclusion
- Pregnant women who don't agree to participate;
- Pregnant women delivering babies at other hospitals.
- Prenatally suspected anomalies that are not confirmed by postnatal diagnosis.
Key Trial Info
Start Date :
May 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2038
Estimated Enrollment :
10000 Patients enrolled
Trial Details
Trial ID
NCT03398629
Start Date
May 1 2019
End Date
March 1 2038
Last Update
June 4 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Guangzhou Women and Children's Medical Center
Guangzhou, Guangdong, China, 510623